Skip to content

Net Income at other companies

Baxter International logo
Baxter InternationalBAX
-$15M-112%
AMP
Amphastar PharmaceuticalsAMPH
$6.42M-74.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$42.67M+49.7%
Royalty Pharma logo
Royalty PharmaRPRX
$294.69M+23.1%
PTH
Pelthos Therapeutics Inc.PTHS
-$10.24M-420%
XOMA Corporation logo
XOMA CorporationXOMA
$4.47M+88.6%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s net income?
Talphera, Inc. (TLPH) reported net income of -$2.56M in Q1 2026.
How has Talphera, Inc.'s net income changed year-over-year?
Talphera, Inc.'s net income increased by 1.4% year-over-year, from -$2.59M to -$2.56M.
What is the long-term trend for Talphera, Inc.'s net income?
Over 3 years (2021 to 2025), Talphera, Inc.'s net income has grown at a -25.9% compound annual growth rate (CAGR), from -$35.1M to -$14.29M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.